Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT L FERRIS

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1851364509
CMS profile
265316
Location
RALEIGH, NC

General Payments · PY2018–2024

$168,578.47

  • Reported across 180 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$40,106.63

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $38,257.00 11
Travel and Lodging $934.56 7
Food and Beverage $915.07 11

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $17,466.82 19
Merck KGaA $6,205.00 1
GlaxoSmithKline, LLC. $4,918.50 2
Merck Sharp & Dohme Corporation $4,270.00 1
PFIZER INC. $3,600.00 1
AstraZeneca UK Limited $3,326.14 2
Coherus Biosciences Inc. $225.39 2
Acerta Pharma LLC $94.78 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $19,796.21 34
PY2019 $38,225.17 56
PY2020 $17,032.00 8
PY2021 $14,353.27 7
PY2022 $17,786.01 10
PY2023 $21,279.18 36
PY2024 $40,106.63 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $94.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 1123310022 CMS
AstraZeneca UK Limited $76.14 09/14/2024 Food and Beverage Undisputed 01/23/2026 1123303386 CMS
AstraZeneca UK Limited $3,250.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1123306482 CMS
Coherus Biosciences Inc. $83.12 01/03/2024 Food and Beverage Undisputed 01/23/2026 1147276180 CMS
Coherus Biosciences Inc. $142.27 06/01/2024 Food and Beverage Undisputed 01/23/2026 1147276264 CMS
GlaxoSmithKline, LLC. $2,518.50 04/25/2024 Consulting Fee Undisputed 01/23/2026 1116426775 CMS
GlaxoSmithKline, LLC. $2,400.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1116558293 CMS
Merck KGaA $6,205.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1133237973 CMS
Merck Sharp & Dohme LLC $4,270.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 1141552110 CMS
PFIZER INC. $3,600.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1132062480 CMS
Regeneron Pharmaceuticals, Inc. $3,460.00 01/08/2024 Consulting Fee Undisputed 01/23/2026 1114398731 CMS
Regeneron Pharmaceuticals, Inc. $1,297.50 06/07/2024 Consulting Fee Undisputed 01/23/2026 1114398733 CMS
Regeneron Pharmaceuticals, Inc. $175.22 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1114398735 CMS
Regeneron Pharmaceuticals, Inc. $175.22 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1114398737 CMS
Regeneron Pharmaceuticals, Inc. $35.25 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1114398739 CMS
Regeneron Pharmaceuticals, Inc. $35.25 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1114398741 CMS
Regeneron Pharmaceuticals, Inc. $308.33 11/11/2024 Travel and Lodging Undisputed 01/23/2026 1114398743 CMS
Regeneron Pharmaceuticals, Inc. $124.23 11/16/2024 Food and Beverage Undisputed 01/23/2026 1114398745 CMS
Regeneron Pharmaceuticals, Inc. $70.97 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1114398747 CMS
Regeneron Pharmaceuticals, Inc. $134.32 11/19/2024 Travel and Lodging Undisputed 01/23/2026 1114398749 CMS
Regeneron Pharmaceuticals, Inc. $39.41 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114398751 CMS
Regeneron Pharmaceuticals, Inc. $35.52 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114398753 CMS
Regeneron Pharmaceuticals, Inc. $76.40 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114398755 CMS
Regeneron Pharmaceuticals, Inc. $39.41 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114398757 CMS
Regeneron Pharmaceuticals, Inc. $105.90 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114398759 CMS
Regeneron Pharmaceuticals, Inc. $97.89 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114398761 CMS
Regeneron Pharmaceuticals, Inc. $938.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1114398763 CMS
Regeneron Pharmaceuticals, Inc. $6,566.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1114398765 CMS
Regeneron Pharmaceuticals, Inc. $3,752.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1114398767 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.